BC
CRSP icon

Belmont Capital’s CRISPR Therapeutics CRSP Stock Holding History

Belmont Capital’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,000
Closed -$90.8K – 169
2023
Q3 		$90.8K Buy
+2,000
New +$90.8K 0.05% 95